跳至主要内容
临床试验/NCT07600008
NCT07600008招募中1 期

Development of a Preparation for Supportive Supplementation of Probiotics in Patients With Reflux

University Hospital Olomouc1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年1月15日最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
50
试验地点
1

研究概览

简要总结

A two-arm, double-blind, randomized, placebo-controlled study investigating the efficacy of a probiotic preparation developed as supportive supplementation of probiotics in patients with reflux.

The objective of this trial is to evaluate the effect of the probiotic dietary supplement on the diversity and composition of the gut microbiome in patients diagnosed with GERD who are on PPI therapy. The study will also monitor changes in the oral microbiome and the impact of probiotic supplementation on patient quality of life and GERD symptoms.

Patients will take the probiotic preparation, 2 tablets twice daily (morning before meals and evening after meals). The experimental phase will last 6 weeks. Patients in the control arm will receive placebo. Supplementation will be discontinued if adverse effects occur.

Oral and rectal swabs will be taken before and after administration of the preparation. Patients will monitor their symptoms using a questionnaire.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
40 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed GERD.
  • Stable health without current complications.
  • Patients on stable pharmacological PPI therapy (rabeprazole).

排除标准

  • Use of probiotics or prebiotics within the last 4 weeks.
  • Pregnancy or breastfeeding.
  • Systemic antimicrobial therapy within the last 4 weeks.
  • Infectious disease of the respiratory or gastrointestinal tract within the last 2 weeks.
  • Serious chronic disease that could affect study results, including cancer, diabetes, inflammatory bowel disease, diagnosed SIBO.
  • Prior surgeries, especially fundoplication and resections of the esophagus or stomach.
  • Patients with psychiatric or cognitive disorders.
  • Hypersensitivity to components of the investigational product.

研究者

发起方
University Hospital Olomouc
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验